Etanercept
Etanercept is a recombinant human receptor fusion protein that suppresses, as a contestant, the interaction of TNF-α with cell surface receptors. It received FDA approval in 1999 to be used in children older than 2 years for the treatment of juvenile idiopathic arthritis. In September 2004, it recei...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Society of Dermatology and Venereology
2022-04-01
|
| Saila: | Turkderm Turkish Archives of Dermatology and Venereology |
| Gaiak: | |
| Sarrera elektronikoa: | https://journal.turkderm.org.tr/jvi.aspx?pdir=turkderm&plng=eng&volume=56&supp=1&Year=2022 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
